Cuizhi Geng
Hebei Medical University(CN)Yanbian University(CN)Peking University(CN)National Clinical Research Center for Digestive Diseases(CN)Fourth Hospital of Hebei Medical University(CN)Breast Center(CH)National Clinical Research(US)Peking University Third Hospital(CN)Chuxiong Normal University(CN)Taian City Central Hospital(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, MicroRNA in disease regulation, Circular RNAs in diseases
Most-Cited Works
- → Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer(2021)700 cited
- → Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial(2021)378 cited
- → Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial(2019)264 cited
- → Biomarkers for EMT and MET in breast cancer: An update(2016)127 cited
- → Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs(2018)100 cited
- →